Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Study protocol

A combination strategy for enhancing linkage to and retention in HIV care among adults newly diagnosed with HIV in Mozambique: study protocol for a site-randomized implementation science study

Authors: Batya Elul, Maria Lahuerta, Fatima Abacassamo, Matthew R Lamb, Laurence Ahoua, Margaret L McNairy, Maria Tomo, Deborah Horowitz, Roberta Sutton, Antonio Mussa, Danielle Gurr, Ilesh Jani

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Despite the extraordinary scale up of HIV prevention, care and treatment services in sub-Saharan Africa (SSA) over the past decade, the overall effectiveness of HIV programs has been significantly hindered by high levels of attrition across the HIV care continuum. Data from “real-life” settings are needed on the effectiveness of an easy to deliver package of services that can improve overall performance of the HIV care continuum.

Methods/Design

We are conducting an implementation science study using a two-arm cluster site-randomized design to determine the effectiveness of a combination intervention strategy (CIS) using feasible, evidence-based, and practical interventions—including (1) point-of-care (POC) CD4 count testing, (2) accelerated antiretroviral therapy initiation for eligible individuals, and (3) SMS reminders for linkage to and retention in care—as compared to the standard of care (SOC) in Mozambique in improving linkage and retention among adults following HIV diagnosis. A pre-post intervention two-sample design is nested within the CIS arm to assess the incremental effectiveness of the CIS plus financial incentives (CIS + FI) compared to the CIS without FI on study outcomes. Randomization is done at the level of the study site, defined as a primary health facility. Five sites are included from the City of Maputo and five from Inhambane Province. Target enrollment is a total of 2,250 adults: 750 in the SOC arm, 750 in the CIS cohort of the intervention arm and 750 in the CIS + FI cohort of the intervention arm (average of 150 participants per site). Participants are followed for 12 months from time of HIV testing to ascertain a combined endpoint of linkage to care within 1 month after testing and retention in care 12 months from HIV test. Cost-effectiveness analyses of CIS compared to SOC and CIS + FI compared to CIS will also be conducted.

Discussion

Study findings will provide evidence on the effectiveness of a CIS and the incremental effectiveness of a CIS + FI in a “real-life” service delivery system in a SSA country severely impacted by HIV.

Trial registration

Clinicaltrials.gov, NCT01930084
Appendix
Available only for authorised users
Literature
1.
go back to reference Fox MP, Rosen S: Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010, 15 (Suppl 1): 1-15. 10.1111/j.1365-3156.2010.02508.x.CrossRefPubMedPubMedCentral Fox MP, Rosen S: Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010, 15 (Suppl 1): 1-15. 10.1111/j.1365-3156.2010.02508.x.CrossRefPubMedPubMedCentral
2.
go back to reference Mugglin C, Estill J, Wandeler G, Bender N, Gsponer T, Egger M, Keiser O: Meta-analysis of linkage to care from HIV diagnosis to start of ART: sub-Saharan Africa. 19th Conference on Retroviruses and Opportunistic Infections (CROI); 5-8 March 2012; Seattle. 2012, Abstract 1143 Mugglin C, Estill J, Wandeler G, Bender N, Gsponer T, Egger M, Keiser O: Meta-analysis of linkage to care from HIV diagnosis to start of ART: sub-Saharan Africa. 19th Conference on Retroviruses and Opportunistic Infections (CROI); 5-8 March 2012; Seattle. 2012, Abstract 1143
3.
go back to reference Rosen S, Fox MP: Retention in HIV care between testing and treatment in ub-Saharan Africa: a systematic review. PLoS Med. 2011, 8 (7): e1001056-10.1371/journal.pmed.1001056.CrossRefPubMedPubMedCentral Rosen S, Fox MP: Retention in HIV care between testing and treatment in ub-Saharan Africa: a systematic review. PLoS Med. 2011, 8 (7): e1001056-10.1371/journal.pmed.1001056.CrossRefPubMedPubMedCentral
4.
go back to reference Rosen S, Fox MP, Gill CJ: Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007, 4 (10): e298-10.1371/journal.pmed.0040298.CrossRefPubMedPubMedCentral Rosen S, Fox MP, Gill CJ: Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007, 4 (10): e298-10.1371/journal.pmed.0040298.CrossRefPubMedPubMedCentral
5.
go back to reference McNairy ML, El-Sadr WM: The HIV care continuum: no partial credit given. AIDS. 2012, 26 (14): 1735-1738. 10.1097/QAD.0b013e328355d67b.CrossRefPubMed McNairy ML, El-Sadr WM: The HIV care continuum: no partial credit given. AIDS. 2012, 26 (14): 1735-1738. 10.1097/QAD.0b013e328355d67b.CrossRefPubMed
6.
go back to reference Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T, Keiser O: Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health. 2012, 17 (12): 1509-1520. 10.1111/j.1365-3156.2012.03089.x.CrossRefPubMedPubMedCentral Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T, Keiser O: Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health. 2012, 17 (12): 1509-1520. 10.1111/j.1365-3156.2012.03089.x.CrossRefPubMedPubMedCentral
7.
go back to reference Barker PM, Mphatswe W, Rollins N: Antiretroviral drugs in the cupboard are not enough: the impact of health systems’ performance on mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2011, 56 (2): e45-e48. 10.1097/QAI.0b013e3181fdbf20.CrossRefPubMed Barker PM, Mphatswe W, Rollins N: Antiretroviral drugs in the cupboard are not enough: the impact of health systems’ performance on mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2011, 56 (2): e45-e48. 10.1097/QAI.0b013e3181fdbf20.CrossRefPubMed
8.
go back to reference Fisher JD, Smith L: Secondary prevention of HIV infection: the current state of prevention for positives. Curr Opin HIV AIDS. 2009, 4 (4): 279-287. 10.1097/COH.0b013e32832c7ce5.CrossRefPubMedPubMedCentral Fisher JD, Smith L: Secondary prevention of HIV infection: the current state of prevention for positives. Curr Opin HIV AIDS. 2009, 4 (4): 279-287. 10.1097/COH.0b013e32832c7ce5.CrossRefPubMedPubMedCentral
9.
go back to reference Fisher JD, Smith LR, Lenz EM: Secondary prevention of HIV in the United States: past, current, and future perspectives. J Acquir Immune Defic Syndr. 2010, 55 (Suppl 2): S106-S115. 10.1097/QAI.0b013e3181fbca2f.CrossRefPubMedPubMedCentral Fisher JD, Smith LR, Lenz EM: Secondary prevention of HIV in the United States: past, current, and future perspectives. J Acquir Immune Defic Syndr. 2010, 55 (Suppl 2): S106-S115. 10.1097/QAI.0b013e3181fbca2f.CrossRefPubMedPubMedCentral
10.
go back to reference Lawn SD, Campbell L, Kaplan R, Boulle A, Cornell M, Kerschberger B, Morrow C, Little F, Egger M, Wood R: Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa. J Acquir Immune Defic Syndr. 2011, 57 (2): 136-140. 10.1097/QAI.0b013e3182199ee9.CrossRefPubMedPubMedCentral Lawn SD, Campbell L, Kaplan R, Boulle A, Cornell M, Kerschberger B, Morrow C, Little F, Egger M, Wood R: Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa. J Acquir Immune Defic Syndr. 2011, 57 (2): 136-140. 10.1097/QAI.0b013e3182199ee9.CrossRefPubMedPubMedCentral
11.
go back to reference Lawn SD, Kranzer K, Wood R: Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med. 2009, 30 (4): 685-699. 10.1016/j.ccm.2009.08.010. viiiCrossRefPubMedPubMedCentral Lawn SD, Kranzer K, Wood R: Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med. 2009, 30 (4): 685-699. 10.1016/j.ccm.2009.08.010. viiiCrossRefPubMedPubMedCentral
12.
go back to reference Makadzange AT, Ndhlovu CE, Takarinda K, Reid M, Kurangwa M, Gona P, Hakim JG: Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-Saharan Africa. Clin Infect Dis. 2010, 50 (11): 1532-1538. 10.1086/652652.CrossRefPubMed Makadzange AT, Ndhlovu CE, Takarinda K, Reid M, Kurangwa M, Gona P, Hakim JG: Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-Saharan Africa. Clin Infect Dis. 2010, 50 (11): 1532-1538. 10.1086/652652.CrossRefPubMed
13.
go back to reference Middelkoop K, Bekker LG, Myer L, Johnson LF, Kloos M, Morrow C, Wood R: Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community. J Acquir Immune Defic Syndr. 2011, 56 (3): 263-269. 10.1097/QAI.0b013e31820413b3.CrossRefPubMedPubMedCentral Middelkoop K, Bekker LG, Myer L, Johnson LF, Kloos M, Morrow C, Wood R: Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community. J Acquir Immune Defic Syndr. 2011, 56 (3): 263-269. 10.1097/QAI.0b013e31820413b3.CrossRefPubMedPubMedCentral
14.
go back to reference Middelkoop K, Bekker LG, Myer L, Whitelaw A, Grant A, Kaplan G, McIntyre J, Wood R: Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. Am J Respir Crit Care Med. 2010, 182 (8): 1080-1085. 10.1164/rccm.201004-0598OC.CrossRefPubMedPubMedCentral Middelkoop K, Bekker LG, Myer L, Whitelaw A, Grant A, Kaplan G, McIntyre J, Wood R: Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. Am J Respir Crit Care Med. 2010, 182 (8): 1080-1085. 10.1164/rccm.201004-0598OC.CrossRefPubMedPubMedCentral
15.
go back to reference Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD: Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2012, 15 (2): 17383-10.7448/IAS.15.2.17383.CrossRefPubMedPubMedCentral Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD: Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2012, 15 (2): 17383-10.7448/IAS.15.2.17383.CrossRefPubMedPubMedCentral
16.
go back to reference Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H, Coutinho A, Jaffar S: Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009, 9: 290-10.1186/1471-2458-9-290.CrossRefPubMedPubMedCentral Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H, Coutinho A, Jaffar S: Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009, 9: 290-10.1186/1471-2458-9-290.CrossRefPubMedPubMedCentral
17.
go back to reference Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, Yiannoutsos CT, Glidden DV, Deeks SG, Martin JN: Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr. 2010, 53 (3): 405-411. 10.1097/QAI.0b013e3181b843f0.CrossRefPubMedPubMedCentral Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, Yiannoutsos CT, Glidden DV, Deeks SG, Martin JN: Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr. 2010, 53 (3): 405-411. 10.1097/QAI.0b013e3181b843f0.CrossRefPubMedPubMedCentral
18.
go back to reference Maskew M, MacPhail P, Menezes C, Rubel D: Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J. 2007, 97 (9): 853-857.PubMed Maskew M, MacPhail P, Menezes C, Rubel D: Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J. 2007, 97 (9): 853-857.PubMed
19.
go back to reference Ochieng-Ooko V, Ochieng D, Sidle JE, Holdsworth M, Wools-Kaloustian K, Siika AM, Yiannoutsos CT, Owiti M, Kimaiyo S, Braitstein P: Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. Bull World Health Organ. 2010, 88 (9): 681-688. 10.2471/BLT.09.064329.CrossRefPubMedPubMedCentral Ochieng-Ooko V, Ochieng D, Sidle JE, Holdsworth M, Wools-Kaloustian K, Siika AM, Yiannoutsos CT, Owiti M, Kimaiyo S, Braitstein P: Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. Bull World Health Organ. 2010, 88 (9): 681-688. 10.2471/BLT.09.064329.CrossRefPubMedPubMedCentral
20.
go back to reference Rabkin M, Austin J, Nash D: High Patient Retention Rates in a Multinational HIV/AIDS Treatment Program: The Columbia University Mother-to-Child-Plus Experience. 17th Conference on Retroviruses and Opportunistic Infections (CROI); 16–19 February 2010; San Francisco. 2010 Rabkin M, Austin J, Nash D: High Patient Retention Rates in a Multinational HIV/AIDS Treatment Program: The Columbia University Mother-to-Child-Plus Experience. 17th Conference on Retroviruses and Opportunistic Infections (CROI); 16–19 February 2010; San Francisco. 2010
21.
go back to reference Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ, Harries AD: True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bull World Health Organ. 2007, 85 (7): 550-554. 10.2471/BLT.06.037739.CrossRefPubMedPubMedCentral Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ, Harries AD: True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bull World Health Organ. 2007, 85 (7): 550-554. 10.2471/BLT.06.037739.CrossRefPubMedPubMedCentral
22.
go back to reference Faal M, Naidoo N, Makgamatha L, Venter F, Osih R: Effect of an immediate CD4 result during VCT on patient retention in ART. XVIII International AIDS Conference; 18–23 July 2010; Vienna. 2010, Abstract TUPE0113 Faal M, Naidoo N, Makgamatha L, Venter F, Osih R: Effect of an immediate CD4 result during VCT on patient retention in ART. XVIII International AIDS Conference; 18–23 July 2010; Vienna. 2010, Abstract TUPE0113
23.
go back to reference Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, Lehe JD, Peter TF: Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet. 2011, 378 (9802): 1572-1579. 10.1016/S0140-6736(11)61052-0.CrossRefPubMed Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, Lehe JD, Peter TF: Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet. 2011, 378 (9802): 1572-1579. 10.1016/S0140-6736(11)61052-0.CrossRefPubMed
24.
go back to reference Larson BA, Ndibongo B, Bistline K, Xulu T, Brennan A, Long L, Maotoe T, Rosen S, Fox MP: Point-of-care CD4 testing after HIV diagnosis to reduce losses to initiation of antiretroviral therapy: an evaluation of a pilot program at the Thembu Lethu Clinic, Johannesburg, South Africa. 6th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention; 17–20 July 2011; Rome. 2011, Abstract no. MOPE450 Larson BA, Ndibongo B, Bistline K, Xulu T, Brennan A, Long L, Maotoe T, Rosen S, Fox MP: Point-of-care CD4 testing after HIV diagnosis to reduce losses to initiation of antiretroviral therapy: an evaluation of a pilot program at the Thembu Lethu Clinic, Johannesburg, South Africa. 6th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention; 17–20 July 2011; Rome. 2011, Abstract no. MOPE450
25.
go back to reference Emenyonu N, Muyindike W, Habyarimana J, Pops-Eleches C, Thirumurthy H, Ragland K, Bangsberg DR: Cash transfers to cover clinic transportation costs improve retention in care in a HIV treatment program in rural Uganda. 17th Conference on Retroviruses and Opportunistic Infections; 16–19 February 2010; San Francisco. 2010, Abstract no. 831 Emenyonu N, Muyindike W, Habyarimana J, Pops-Eleches C, Thirumurthy H, Ragland K, Bangsberg DR: Cash transfers to cover clinic transportation costs improve retention in care in a HIV treatment program in rural Uganda. 17th Conference on Retroviruses and Opportunistic Infections; 16–19 February 2010; San Francisco. 2010, Abstract no. 831
29.
go back to reference Micek MA, Gimbel-Sherr K, Baptista AJ, Matediana E, Montoya P, Pfeiffer J, Melo A, Gimbel-Sherr S, Johnson W, Gloyd S: Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr. 2009, 52 (3): 397-405. 10.1097/QAI.0b013e3181ab73e2.CrossRefPubMedPubMedCentral Micek MA, Gimbel-Sherr K, Baptista AJ, Matediana E, Montoya P, Pfeiffer J, Melo A, Gimbel-Sherr S, Johnson W, Gloyd S: Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr. 2009, 52 (3): 397-405. 10.1097/QAI.0b013e3181ab73e2.CrossRefPubMedPubMedCentral
30.
go back to reference Lahuerta M, Lima J, Elul B, Okamura M, Alvim MF, Nuwagaba-Biribonwoha H, Horowitz D, Fernandes R, Assan A, Abrams EJ, El-Sadr WM, Nash D: Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes. J Acquir Immune Defic Syndr. 2011, 58 (3): e75-e86. 10.1097/QAI.0b013e31822ac0a9.CrossRefPubMedPubMedCentral Lahuerta M, Lima J, Elul B, Okamura M, Alvim MF, Nuwagaba-Biribonwoha H, Horowitz D, Fernandes R, Assan A, Abrams EJ, El-Sadr WM, Nash D: Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes. J Acquir Immune Defic Syndr. 2011, 58 (3): e75-e86. 10.1097/QAI.0b013e31822ac0a9.CrossRefPubMedPubMedCentral
31.
go back to reference Palladino C, Briz V, Bellon JM, Bartolo I, Carvalho P, Camacho R, Munoz-Fernandez MA, Bastos R, Manuel R, Casanovas J, Taveira N: Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique. PLoS One. 2013, 8 (12): e82718-10.1371/journal.pone.0082718.CrossRefPubMedPubMedCentral Palladino C, Briz V, Bellon JM, Bartolo I, Carvalho P, Camacho R, Munoz-Fernandez MA, Bastos R, Manuel R, Casanovas J, Taveira N: Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique. PLoS One. 2013, 8 (12): e82718-10.1371/journal.pone.0082718.CrossRefPubMedPubMedCentral
32.
go back to reference Pati R, Lahuerta M, Elul B, Okamura M, Alvim MF, Schackman B, Bang H, Fernandes R, Assan A, Lima J, Nash D: Factors associated with loss to clinic among HIV patients not yet known to be eligible for antiretroviral therapy (ART) in Mozambique. J Int AIDS Soc. 2013, 16: 18490-10.7448/IAS.16.1.18490.CrossRefPubMedPubMedCentral Pati R, Lahuerta M, Elul B, Okamura M, Alvim MF, Schackman B, Bang H, Fernandes R, Assan A, Lima J, Nash D: Factors associated with loss to clinic among HIV patients not yet known to be eligible for antiretroviral therapy (ART) in Mozambique. J Int AIDS Soc. 2013, 16: 18490-10.7448/IAS.16.1.18490.CrossRefPubMedPubMedCentral
33.
go back to reference Elul B, Saito S, Hoos D, Lamb M, de Lima J, Hawken M, Ntumy R, Awa-Toure M, Melaku Z, El-Sadr WM: 6- and 12-month non-retention over time among 5,690 cohorts with 316,762 patients initiating ART: 9 countries in sub-Saharan Africa. 19th Conference on Retroviruses and Opportunistic Infections; 5–8 March 2012; Seattle. 2012, Abstract no. 86 Elul B, Saito S, Hoos D, Lamb M, de Lima J, Hawken M, Ntumy R, Awa-Toure M, Melaku Z, El-Sadr WM: 6- and 12-month non-retention over time among 5,690 cohorts with 316,762 patients initiating ART: 9 countries in sub-Saharan Africa. 19th Conference on Retroviruses and Opportunistic Infections; 5–8 March 2012; Seattle. 2012, Abstract no. 86
34.
go back to reference Donner A, Klar N: Design and Analysis of Cluster Randomization Trials in Health Research. 2000, Arnold, London Donner A, Klar N: Design and Analysis of Cluster Randomization Trials in Health Research. 2000, Arnold, London
Metadata
Title
A combination strategy for enhancing linkage to and retention in HIV care among adults newly diagnosed with HIV in Mozambique: study protocol for a site-randomized implementation science study
Authors
Batya Elul
Maria Lahuerta
Fatima Abacassamo
Matthew R Lamb
Laurence Ahoua
Margaret L McNairy
Maria Tomo
Deborah Horowitz
Roberta Sutton
Antonio Mussa
Danielle Gurr
Ilesh Jani
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-014-0549-5

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.